In our previous studies, we have demonstrated that shikonin can induce necroptosis in glioma cells, activate its downstream signaling factor MLKL by activating RIP1 and RIP3, and promote chromatinolysis by causing nuclear translocation of AIF and the formation of γ-H2AX13. This evidence concerns the gene AIFM1 and central nervous system cancer.